FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:1961-1963 December 28, 2000 Number 26 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Whitney, C. G. Related Article by Donskey, C. J. PubMed Citation

One hundred years ago, the three major causes of death in the United States were tuberculosis, pneumonia, and gastrointestinal infections. Subsequently, the advent of antibiotics resulted in a major decline in the incidence of life-threatening infections in the developed world. By the end of the 20th century, only lower respiratory tract infections still ranked among the top 10 causes of death. As we approach January 2001, however, the unforgiving rise in the frequency of multidrug resistance among leading pathogens should cause great concern and incite a commitment to act responsibly.

The pneumococcus is arguably the most important cause of community-acquired . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Finkelstein, J. A., Huang, S. S., Kleinman, K., Rifas-Shiman, S. L., Stille, C. J., Daniel, J., Schiff, N., Steingard, R., Soumerai, S. B., Ross-Degnan, D., Goldmann, D., Platt, R. (2008). Impact of a 16-Community Trial to Promote Judicious Antibiotic Use in Massachusetts. Pediatrics 121: e15-e23 [Abstract] [Full Text]  
• Aujesky, D., Fine, M. J. (2005). Does Guideline Adherence for Empiric Antibiotic Therapy Reduce Mortality in Community-acquired Pneumonia?. Am. J. Respir. Crit. Care Med. 172: 655-656 [Full Text]  
• Pini, A., Giuliani, A., Falciani, C., Runci, Y., Ricci, C., Lelli, B., Malossi, M., Neri, P., Rossolini, G. M., Bracci, L. (2005). Antimicrobial Activity of Novel Dendrimeric Peptides Obtained by Phage Display Selection and Rational Modification. Antimicrob. Agents Chemother. 49: 2665-2672 [Abstract] [Full Text]  
• Akkerman, A. E., van der Wouden, J. C., Kuyvenhoven, M. M., Dieleman, J. P., Verheij, T. J. M. (2004). Antibiotic prescribing for respiratory tract infections in Dutch primary care in relation to patient age and clinical entities. J Antimicrob Chemother 54: 1116-1121 [Abstract] [Full Text]  
• Schentag, J. J, Meagher, A. K, Forrest, A. (2003). Fluoroquinolone AUIC Break Points and the Link to Bacterial Killing Rates Part 2: Human Trials. The Annals of Pharmacotherapy 37: 1478-1488 [Abstract] [Full Text]  
• Annane, D., Aegerter, P., Jars-Guincestre, M. C., Guidet, B. (2003). Current Epidemiology of Septic Shock: The CUB-Rea Network. Am. J. Respir. Crit. Care Med. 168: 165-172 [Abstract] [Full Text]  
• Taylor, J. A., Kwan-Gett, T. S. C., McMahon, E. M. Jr (2003). Effectiveness of an Educational Intervention in Modifying Parental Attitudes About Antibiotic Usage in Children. Pediatrics 111: e548-554 [Abstract] [Full Text]  
• Martin, G. S., Mannino, D. M., Eaton, S., Moss, M. (2003). The Epidemiology of Sepsis in the United States from 1979 through 2000. NEJM 348: 1546-1554 [Abstract] [Full Text]  
• Chan, P. F., O'Dwyer, K. M., Palmer, L. M., Ambrad, J. D., Ingraham, K. A., So, C., Lonetto, M. A., Biswas, S., Rosenberg, M., Holmes, D. J., Zalacain, M. (2003). Characterization of a Novel Fucose-Regulated Promoter (PfcsK) Suitable for Gene Essentiality and Antibacterial Mode-of-Action Studies in Streptococcus pneumoniae. J. Bacteriol. 185: 2051-2058 [Abstract] [Full Text]  
• Bratzler, D. W., Houck, P. M., Jiang, H., Nsa, W., Shook, C., Moore, L., Red, L. (2002). Failure to Vaccinate Medicare Inpatients: A Missed Opportunity. Arch Intern Med 162: 2349-2356 [Abstract] [Full Text]  
• CANT, A.J., GORDON, S.B., READ, R.C., HART, C.A., WINSTANLEY, C. (2002). Respiratory infections: Proceedings of the Eighth Liverpool Tropical School Bayer Symposium of Microbial Disease held on 3 February 2001. J Med Microbiol 51: 903-914 [Full Text]  
• Conly, J. (2002). Antimicrobial resistance in Canada. CMAJ 167: 885-891 [Abstract] [Full Text]  
• Perz, J. F., Craig, A. S., Coffey, C. S., Jorgensen, D. M., Mitchel, E., Hall, S., Schaffner, W., Griffin, M. R. (2002). Changes in Antibiotic Prescribing for Children After a Community-wide Campaign. JAMA 287: 3103-3109 [Abstract] [Full Text]  
• Eggimann, P., Pittet, D. (2001). Infection Control in the ICU. Chest 120: 2059-2093 [Abstract] [Full Text]  
• Osmon, D. R. (2001). Antimicrobial Resistance: Guidelines for the Practicing Orthopaedic Surgeon. JBJS 83: 1891-1901 [Full Text]  
• Bauchner, H., Osganian, S., Smith, K., Triant, R. (2001). Improving Parent Knowledge About Antibiotics: A Video Intervention. Pediatrics 108: 845-850 [Abstract] [Full Text]  
• Chey, W. D., Fendrick, A. M. (2001). Noninvasive Helicobacter pylori Testing for the "Test-and-Treat" Strategy: A Decision Analysis to Assess the Effect of Past Infection on Test Choice. Arch Intern Med 161: 2129-2132 [Abstract] [Full Text]  
• Foster, D. A., Heller, S. T., Young, J. K., Tayloe, D., Wilbur, R. S., Whitney, C. G., Wenzel, R. P., Edmond, M. B. (2001). Multidrug-Resistant Streptococcus pneumoniae. NEJM 344: 1329-1331 [Full Text]  
• (2001). Worrisome Increase in Multidrug-Resistant Pneumococci. JWatch Infect. Diseases 2001: 5-5 [Full Text]  
• (2001). Does Antianaerobic Therapy Enhance VRE Infection?. JWatch Infect. Diseases 2001: 7-7 [Full Text]